Guilherme Dabus, MD
@gdabus
interventional neuroradiologist, neuroendovascular surgeon, semi-pro guitarist, basketball-swimming-tennis weekend coach (when not on call!!!)
You might like
University of Oregon enrolled the last patient in #HEMERA 1 This concludes phase 1 trial!#stroke @RaulNogueiraMD @DiogoHaussen @AmeerEHassan @almuftifawaz @DanielVelaMD @NguyenThanhMD @docroc99 @JoshuaAHirsch @gdabus @DrBTKatzen @dliebesk @svinsociety @AliciaCastongu2 @VladoKZg
Thank you #SNIS for having me presenting #HEMERA 1 data and the Propensity Score Analysis at #SNIS2025 @DrAltschul @gdabus @RaulNogueiraMD @BaptistHealthSF @DanielVelaMD @DrJessicaCampos @SNISinfo @NN_publishing @AshuPJadhav @svinsociety @SVINJournal
Only 1 week left until #MiamiNeuro23 where the expert faculty will share the latest treatments for neurological conditions including #stroke, subarachnoid hemorrhage, #epilepsy, #dementia, and #multiplesclerosis as well as robust discussion on the latest advancements in…
Kudos to Dr. Guilherme Dabus (@gdabus) for recently presenting results from the SUMMIT MAX trial at @ESOstroke #ESOC2025 in Helsinki.
The Hi-Point reperfusion system (.088"/.070") was non-inferior and superior to the Vecta aspiration system (.074"/.071") in successful reperfusion. - High deliverability to M1 - High First Pass effect - Lower use of adjunctive devices - Similar Safety and Clinical outcomes
Thank you to all Investigators and their team for enrolling patients into SUMMIT MAX
SUMMIT MAX: A randomized trial of the super large bore HiPoint Reperfusion System versus Vecta System for aspiration thrombectomy | Stroke ahajournals.org/doi/10.1161/ST… Presented this morning at #ESOC2025 with @gdabus @ajitspuri1 et al. in Helsinki
🌟Presented today at #ESOC2025: SUMMIT MAX: A randomized trial of the super large bore HiPoint Reperfusion System versus Vecta System for aspiration thrombectomy by @NguyenThanhMD et al. #stroke #AHAJournals @ESOstroke @gdabus ahajournals.org/doi/abs/10.116…
Congratulations to SNIS members @gdabus @HettsSteven @dgandhimd Cliff Eskey & Sudipta Roychowdhury on attaining Fellowship in @RadiologyACR! #FACR #ACR2022
2 of my fellows became FACR tonight. I am so unbelievably proud-literally don’t know what 2 say (which is rare) @gdabus @italolinfante @SNISinfo @MGHImaging #ohwhatanihht!!!!
The classics... legendary historic Neuroradiology books... #neurorad @TheASNR @SNISinfo @esmintsociety @JoshuaAHirsch @Fie0815 @docroc99 @meyerspm @CPDerdeyn @WBrinjikji
📘🧠 HAPPENING SOON: Don't miss today's @JNIS_BMJ Journal Club webinar at 4pm ET. JNIS Social Media Asst. Editor @rdeleacymd will sit down with authors Ricardo Hanel, MD & @_AdnanSiddiqui & discussants @gdabus & Roberta Novakovic, MD. Register today ➡️ register.gotowebinar.com/register/87555…
We all need to do our part! Social distancing, masks, vaccine. The disease is treacherous and that’s the reality for now...@BaptistHealthSF #CovidVaccine
CTA can be helpful in stroke cases so you know what you’re facing: LICA occlusion with a bovine, very tortuous LCCA, aberrant subclavian; walrus bgc, distal aspiration, stentretriever #stroke “know your enemy, know his sword”Musashi
SIMI 2020 Invited professors December 3-4-5 Free registration & info: simi.com.ar
Improvement in device technology is an amazing thing... 088 distal access sheath... good job @imperative_care and thanks to all companies that make our job easier and help improving patient outcome
Excited to be among this international team of experts set to speak at the International Symposium Of Neuroradiology later this month! @DiogoHaussen @gdabus @neurofox @VitorMendesPer1 @FBarkhof @HuismanThierry #Neuroradiology #Neurorad #MedTwitter #MedEd #NeuroTwitter
Everyone should read this! Leadership is all about service, not privileges!!! Ego Is the Enemy of Good Leadership hbr.org/2018/11/ego-is…
hbr.org
Ego Is the Enemy of Good Leadership
The inflated ego that comes with success – the bigger salary, the nicer office, the easy laughs – often makes us feel as if we’ve found the eternal answer to being a leader. But the reality is, we...
The professional and personal impact of the coronavirus pandemic on US neurointerventional practices: a nationwide survey jnis.bmj.com/content/early/…
Rai et al: Neuroendovascular clinical trials disruptions due to COVID-19 potential future challenges and opportunities. ow.ly/4jyY50An74r
United States Trends
- 1. Giannis N/A
- 2. #SmackDown N/A
- 3. Sinner N/A
- 4. Adam 22 N/A
- 5. Bucks N/A
- 6. Trans N/A
- 7. #DragRace N/A
- 8. Jason Luv N/A
- 9. #OPLive N/A
- 10. Spizzirri N/A
- 11. Pacers N/A
- 12. Kuzma N/A
- 13. Dabo N/A
- 14. Aaron Gordon N/A
- 15. Doc Rivers N/A
- 16. Attitude Era N/A
- 17. #ZuffaBoxing01 N/A
- 18. Callum Walsh N/A
- 19. Antarctica N/A
- 20. Jen Z N/A
You might like
-
Demetrius Lopes, MD
@Cure4Stroke -
Vitor Mendes Pereira
@vitorpereiracan -
Felipe C. Albuquerque
@fcalbuquerque51 -
LINNC online 🧠
@LINNConline -
Dileep R. Yavagal
@dyavagal -
Michael Chen, MD
@dr_mchen -
Jildaz Caroff 👨🏻⚕️
@jildazz -
Mario Martínez-Galdámez
@DoctorGaldamez -
Luís H Castro-Afonso
@ikeafonso1 -
IL
@italolinfante -
ENERI - Dr. Pedro Lylyk
@eneri_neuro -
James Milburn MD, FACR, FSNIS, MMM
@docroc99 -
Pedro Magalhaes
@Neurorradio
Something went wrong.
Something went wrong.